RECURSION PHARMACEUTICALS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-57.0M | $-61.0M | $3.9M | $1.4M |
| FY2020 | $-45.4M | $-51.2M | $5.8M | $4.3M |
| FY2021 | $-158.6M | $-198.4M | $39.8M | $14.8M |
| FY2022 | $-83.5M | $-120.6M | $37.1M | $27.9M |
| FY2023 | $-287.8M | $-299.7M | $12.0M | $53.5M |
| FY2024 | $-359.2M | $-372.9M | $13.7M | $81.7M |
| FY2025 | $-371.8M | $-378.3M | $6.5M | $111.2M |